Skye Bioscience: In A Current Report On Form 8k Filed By Skye Bioscience, Inc. (the “company”) On August 14, 2026 (the “original Form 8k”). This Amendment Is Being Filed Solely For The Purpose Of Announcing The Effective Date. Capitalized Terms Used Herein That Are Not Otherwise Defined Shall Have The Meanings Set Forth In The Original Form 8k And, Except As Set Forth Herein, The Original Form 8k Remains Unchanged

Show full article

This functionality is available for registred users only

• Full name
  Skye Bioscience Inc
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***